Are you the publisher? Claim or contact us about this channel


Embed this content in your HTML

Search

Report adult content:

click to rate:

Account: (login)

More Channels


Channel Catalog


Channel Description:

Daily news and press releases about Healthcare

older | 1 | .... | 1031 | 1032 | (Page 1033) | 1034 | 1035 | .... | 1118 | newer

    0 0

     



    (EMAILWIRE.COM, May 09, 2018 ) This report studies Vascular Stents in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2013 to 2018, and forecast to 2025.

    This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

    Medtronic Plc
    Abbott Laboratories
    Boston Scientific Corporation
    Biotronik Se & Co. Kg
    B. Braun Melsungen Ag
    Terumo Corporation
    Microport Scientific Corporation
    Meril Life Sciences Pvt. Ltd.
    Vascular Concepts Limited
    C.R. Bard, Inc.
    W.L. Gore and Associates, Inc.
    Endologix, Inc.
    Lombard Medical
    Translumina Gmbh
    Jotec Gmbh

    Get More Information about this Report @ https://www.planetmarketreports.com/reports/global-vascular-stents-market-4365

    On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Baremetal Stents
    Drugeluting Stents
    Bioabsorbable Stents

    By Application, the market can be split into
    Hospitals & Cardiac Centers
    Ambulatory Surgical Centers

    By Regions, this report covers we can add the regions/countries as you want
    North America
    China
    Europe
    Southeast Asia
    Japan
    India

    Get a Free Sample Copy of this Report @ https://www.planetmarketreports.com/report-sample/global-vascular-stents-market-4365

    Table of Contents

    Vascular Stentsl Market Report 2018

    1. Vascular Stentsl Overview
    2 Vascular Stentsl Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    3 Vascular Stentsl Volumes, Value and Sales Price, by Players, Countries, Type and Application
    4 Vascular Stentsl Volumes, Value and Sales Price, by Region, Type and Application
    5 Vascular Stentsl Volumes, Value and Sales Price by Players, Countries, Type and Application
    6 Vascular Stentsl Manufacturers/Players Profiles and Sales Data
    7 Vascular Stentsl Manufacturing Cost Analysis
    8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    9 Marketing Strategy Analyses, Distributors/Traders
    10 Market Effect Factors Analysis
    11 Vascular Stentsl Market Forecast 2018-2025
    12 Research Findings and Conclusion
    13 Appendixes

    To Browse Similar Reports @ http://www.planetmarketreports.com/category/medical-devices

    About Us :

    Planet Market Reports gives statistical surveying reports to businesses, people and associations with a goal of helping them in their decision making process. We have huge database of market research reports & company profiles across globe. We associated with global market research a publisher who has a wide range of research specialists & industry experts which provides you deeper penetration of market research industry.

    We have statistical surveying reports from number of top publishers and update our reports collections on daily basis with most recent research data to furnish our customers with the moment online access to our database. With access to this database, our customers will be able to benefit from expert insights on worldwide businesses, items, and market patterns. We help you in your buy choice by mapping your data needs with our immense accumulation of reports.

    Contact Us :

    Name: Ronald James

    Email-Id: ronald.james@planetmarketreports.com

    US : +1-716-2260907

    UK : +447441952057

    Organization: Planet Market Reports



    Himesh Khatri
    9834406269
    himesh@planetmarketreports.com

    Source: EmailWire.Com

    0 0

    (EMAILWIRE.COM, May 09, 2018 ) Singapore: A global report titled Biomarkers Market has been introduced into our library of 2.5 million reports.

    About the market report:
    Biomarkers are novel diagnostic tools that provide intelligence to physician about disease progression and treatment effects. Advancement in understanding of human genome promotes its application in diagnosis of disease on molecular basis. Biomarker technology is evidencing increased application in disease diagnosis, drug development and formulation, diagnosis for exposure of certain harmful chemical and prognostic treatments. The global market for diagnostic biomarker is expected to reach about $30.6 billion in 2020, growing at CAGR of 16% from 2013 to 2020. Pharmaceutical companies, which are interested in introducing novel diagnostic solution are increasing partnership and collaboration with private laboratories, and educational institutes. The companies are also increasing their investments in research and development.

    To access the full table of contents of the report click below: rnhttps://www.marketintelreports.com/report/allied0228/biomarkers-market-diagnostic-applications-in-risk-assessment-molecular-diagnostics-disease-diagnosis-drug-discovery-amp-development-drug-formulation-forensic-applications-and-others---global-industry-analysis-emerging-technologies-competitive-intelligence-growth-trends-size-share-opportunities-and-forecast-2013--2020


    Scope of the Report:
    This report focuses on the Biomarkers in global market, especially inSiemens Healthcare (Germany), Abbott Laboratories Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Agilent Technologies Inc. (U.S.), Bio-Rad Laboratories Inc. (U.S.), Aushon BioSystem Inc. (M.A.), Epistem Ltd (U.K.), This report categorizes the market based on manufacturers, regions, types and applications.




    To find out more of the report or request some customization : rnhttps://www.marketintelreports.com/inquiry-before-buying.php?id=allied0228

    Table of Contents-Key Points Covered
    CHAPTER 1 INTRODUCTION
    1.1 Scope and Coverage
    1.2 Report DescriptionCHAPTER
    2 EXECUTIVE SUMMARY
    2.1 Biomarker Diagnosis Vs. Conventional Diagnosis
    2.2 Why Diagnostic Biomarkers are Used in Diagnosis and Drug Development?
    ………….
    6 GLOBAL DIAGNOSTIC BIOMARKER MARKET BY SERVICES, 2013-2020, $MILLION
    6.1 Sample Preparation
    6.1.1 Application
    6.1.1.1 Biological Mass Spectrometry
    6.1.2 Drivers
    6.1.2.1 Cost Effective
    6.1.2.2 Sample Rigidity
    6.1.2.3 Efficient Forensic Studies
    6.1.3 Restraints
    Continued…..

    Complete Report Details @ https://www.marketintelreports.com/report/allied0228/biomarkers-market-diagnostic-applications-in-risk-assessment-molecular-diagnostics-disease-diagnosis-drug-discovery-amp-development-drug-formulation-forensic-applications-and-others---global-industry-analysis-emerging-technologies-competitive-intelligence-growth-trends-size-share-opportunities-and-forecast-2013--2020



    About us:
    MIR intends to be a one-stop shop with an intuitive design, exhaustive database, expert assistance, secure cart checkout and data privacy integrated. It curates the list of reports, publishers and studies to ensure that the database is constantly updated to dynamically meet the targeted, specific needs of our clients.
    MarketIntelReports currently has more than 2.5 million titles and 200 publishers on our platform and are growing consistently to fill the “World Intelligence Demand – Supply Gap”. We cover more than 15 industry verticals being: Automotive, Electronics, Manufacturing, Pharmaceuticals, Healthcare, Chemicals, Building & Construction, Agriculture, Food & Beverages, Banking & Finance, Media and Government, Public Sector Studies.




    Lakshmi
    1-302-261-5343
    sales@marketintelreports.com

    Source: EmailWire.Com

    0 0

    (EMAILWIRE.COM, May 09, 2018 ) Singapore,: A global report titled  Cholera Vaccines Market has been introduced into our library of 2.5 million reports.

    About the market report:
    The cholera vaccines market appears to be concentrated due to the presence of few established players. The major vendors in the market compete based on pricing and presence across the world. The presence of a rich pipeline, strategic partnerships, and operational base are the other major competitive factors among cholera vaccine manufacturers. Cholera vaccines can be segmented into three product types which includes Shanchol, DUKORAL, and Vaxchora. Shanchol segment accounted for the major share of the cholera vaccines market. Cholera is very common in countries such as Congo, Yemen, South Sudan, Mozambique, and Haiti and these countries are the major adopters of Shanchol since this vaccine provides better long-term protection for children especially under the age of six.

    To access the full table of contents of the report click below: rnhttps://www.marketintelreports.com/report/tec-lhc0003/global-cholera-vaccines-market-20182022



    Covered in this report:
    The report covers the present scenario and the growth prospects of the global cholera vaccines market for 2018-2022. To calculate the market size, the report considers the revenue generated from the sales of cholera vaccines.

    The market is divided into the following segments based on geography: 
    • Americas
    • APAC
    • EMEA

    Key vendors :
    • PaxVax
    • Sanofi
    • Valneva

    To find out more of the report or request some customization : rnhttps://www.marketintelreports.com/inquiry-before-buying.php?id=tec-lhc0003

    Table of Contents-Key Points Covered
    PART 01: EXECUTIVE SUMMARY
    PART 02: SCOPE OF THE REPORT
    PART 03: RESEARCH METHODOLOGY
    PART 04: INTRODUCTION
    • Market outline
    PART 05: MARKET LANDSCAPE
    • Market ecosystem
    • Market characteristics
    ………….
    PART 08: PIPELINE LANDSCAPE
    PART 09: MARKET SEGMENTATION BY PRODUCT
    • Overview
    • Comparison by product
    • Shanchol
    • DUKORAL
    • Vaxchora
    • Market opportunity by product
    Continued…..

    Complete Report Details @ https://www.marketintelreports.com/report/tec-lhc0003/global-cholera-vaccines-market-20182022



    About us:
    MIR intends to be a one-stop shop with an intuitive design, exhaustive database, expert assistance, secure cart checkout and data privacy integrated. It curates the list of reports, publishers and studies to ensure that the database is constantly updated to dynamically meet the targeted, specific needs of our clients.
    MarketIntelReports currently has more than 2.5 million titles and 200 publishers on our platform and are growing consistently to fill the “World Intelligence Demand – Supply Gap”. We cover more than 15 industry verticals being: Automotive, Electronics, Manufacturing, Pharmaceuticals, Healthcare, Chemicals, Building & Construction, Agriculture, Food & Beverages, Banking & Finance, Media and Government, Public Sector Studies.



    Lakshmi
    1-302-261-5343
    sales@marketintelreports.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, May 09, 2018 ) Singapore

    About the market report:

    Excess of carbon dioxide found in tissue of normal people can be a problem. Carbon dioxide can build up in the body if a person is overweight or during Consumer. Excess carbon dioxide is toxic. if there is not enough oxygen to balance the carbon dioxide in the body. There needs to be a balance between the oxygen and carbon dioxide. When there is more carbon dioxide than needed in the body, more oxygen is needed to create a balance, supplemental oxygen is needed.

    People who are overweight can build up excess carbon dioxide because every cell in the body creates carbon dioxide. When there are too many cells, the balance between oxygen coming in and carbon dioxide being created in every cell gets off. A lack of balance creates carbon dioxide toxicity in the body. Supplemental oxygen is necessary to create a balance. Oxygen absorbs carbon dioxide and gets the gases inside the body back in balance. When there is an imbalance, the supplemental oxygen is needed, not too much supplemental oxygen, just the right amount.

    To access the full table of contents of the report click below:
    Link to the table of contents: “https://www.marketintelreports.com/report/win002/consumer-oxygen-equipment-market-shares-strategies-and-forecasts-worldwide-2016-to-2022”


    Scope of the Report:

    Supplemental oxygen equipment markets at $3.9 million in 2015 are anticipated to reach $2.8 billion dollars by 2022. Growth is a result of demand for the smaller lighter technology already developed, already on the market, for use by people exercising. The market need by for oxygen generation devices at clubs and gyms is building even as portable devices provide greater mobility support for bike riders, joggers, and older people.

    There are 5 Chapters to deeply display the Consumer Oxygen Equipment market.

    To find out more of the report or request some customization:
    Link to the Inquiry before purchase: “https://www.marketintelreports.com/inquiry-before-buying.php?id=win002”

    Table of Contents-Key Points Covered – Partial paste
    Consumer Oxygen Executive Summary 25
    Consumer Oxygen Equipment market Driving Forces 25
    Consumer Oxygen Market Leaders 32
    Boost Recreational Canned Oxygen 33
    Consumer Oxygen Equipment Forecasts 34
    OHS Patient Symptoms 35
    OHS Treatments with Oxygen 35
    OHS Indicates that Blood Oxygen Saturation and
    Shortness of Breath Are Separate 36
    Football Players, Basket Ball players, and Hockey Players Use
    Oxygen to Support Performance When Exhausted. 37
    Supplemental Oxygen Placebo Effect 38
    Obesity Hypoventilation Syndrome Co2 Loading And Unloading 40
    1. Consumer Oxygen Equipment: Market Description and Market Dynamics 41
    1.1 Value of Consumer 41
    1.2 Respiration 42
    1.2.1 Supplemental Oxygen Good for People Exercising After They Begin to Have Difficulty Breathing 46
    1.3 Oxygen Equipment Separates Oxygen From Air 46
    1.3.1 Portable Oxygen Concentrator Functions 47
    1.4 Oxygen / Ozone Therapy to Strengthen Immune System 48
    1.5 Long History of Supplemental Oxygen Improving Sports Performance 49
    1.6 Supplemental Oxygen to Improve Brain Functioning 51
    1.6.1 Mountaineering Use of Supplemental Oxygen 54
    1.6.2 Summit Oxygen ALTOX Personal Oxygen System 56
    1.7 Oxygen Concentrator Uses 57
    1.7.1 Stationary Oxygen Concentrator Functions 57
    1.7.2 Separation Of Oxygen From Air 58
    1.7.3 Technical Trade-Offs Necessary To Design An Oxygen Concentrator 59
    2. Consumer Oxygen Market Shares and Forecasts 60
    2.1 Consumer Oxygen Equipment Market Driving Forces 60
    2.1.1 Football Players, Basket Ball players, and Hockey Players Use Oxygen to Support Performance When Exhausted. 66
    2.1.2 Supplemental Oxygen Placebo Effect 66
    2.2 Consumer Oxygen Market Leaders 70
    Continued…..

    Complete Report Details @ https://www.marketintelreports.com/report/win002/consumer-oxygen-equipment-market-shares-strategies-and-forecasts-worldwide-2016-to-2022

    About us:

    MIR intends to be a one-stop shop with an intuitive design, exhaustive database, expert assistance, secure cart checkout and data privacy integrated. It curates the list of reports, publishers and studies to ensure that the database is constantly updated to dynamically meet the targeted, specific needs of our clients.

    MarketIntelReports currently has more than 2.5 million titles and 200 publishers on our platform and are growing consistently to fill the “World Intelligence Demand – Supply Gap”. We cover more than 15 industry verticals being: Automotive, Electronics, Manufacturing, Pharmaceuticals, Healthcare, Chemicals, Building & Construction, Agriculture, Food & Beverages, Banking & Finance, Media and Government, Public Sector Studies.


    Lakshmi
    1-302-261-5343
    sales@marketintelreports.com

    Source: EmailWire.Com

    0 0

    (EMAILWIRE.COM, May 09, 2018 ) Singapore : A global report titled Breast Implant Market has been introduced into our library of 2.5 million reports.

    About the market report:
    One of the aspects of modern life that is considered as an essential by men and women is appearance. The desire to look presentable has led to the notable growth in the cosmetology industry. Originally, cosmetic surgery evolved from the reconstructive procedures and as a result, some of its techniques are similar whether they are used for reconstructive or cosmetic purposes. For instance, in various reconstructive procedures, breast implant is a procedure used to gain normal appearance after mastectomy. However, it has a much wider application in cosmetic technique to streamline the body shape.

    To access the full table of contents of the report click below: rnhttps://www.marketintelreports.com/report/irtntr11068/global-breast-implant-market-20162020


    Scope of the Report:
    This report focuses on the Corrugated Plastic Board in global market, especially in Americas, APAC ,EMEA. This report categorizes the market based on manufacturers, regions, types and applications.

    Sample companies covered are Allergan,Mentor Worldwide, GC Aesthetics, Sientra.


    To find out more of the report or request some customization : rnhttps://www.marketintelreports.com/inquiry-before-buying.php?id=irtntr11068

    Table of Contents-Key Points Covered
    PART 01: Executive summary
    Highlights
    PART 02: Scope of the report
    Market overview
    Top-vendor offerings
    PART 03: Market research methodology
    Research methodology
    Economic indicators
    PART 04: Introduction
    Key market highlights
    ………….
    PART 07: Product segmentation
    Global breast implant market by product segmentation
    Global silicone breast implant market
    Global saline breast implant market
    PART 08: Market drivers
    PART 09: Impact of drivers
    PART 10: Market challenges
    PART 11: Impact of drivers and challenges
    PART 12: Market trends
    Continued…..
    Complete Report Details @ https://www.marketintelreports.com/report/irtntr11068/global-breast-implant-market-20162020


    About us:
    MIR intends to be a one-stop shop with an intuitive design, exhaustive database, expert assistance, secure cart checkout and data privacy integrated. It curates the list of reports, publishers and studies to ensure that the database is constantly updated to dynamically meet the targeted, specific needs of our clients.
    MarketIntelReports currently has more than 2.5 million titles and 200 publishers on our platform and are growing consistently to fill the “World Intelligence Demand – Supply Gap”. We cover more than 15 industry verticals being: Automotive, Electronics, Manufacturing, Pharmaceuticals, Healthcare, Chemicals, Building & Construction, Agriculture, Food & Beverages, Banking & Finance, Media and Government, Public Sector Studies.




    Lakshmi
    1-302-261-5343
    sales@marketintelreports.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, May 09, 2018 ) According to new research report Global Point of Care Testing Market is anticipated to reach USD 35.3 billion by 2024 from USD 18.6 billion in 2016, growing at a CAGR of 8.4% in the forecast period 2017 to 2024. The new market report contains data for historic year 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

    To request a free sample copy or view summary of this report, click the link below @ http://databridgemarketresearch.com/request-a-sample/?dbmr=point-care-testing-poct-market
    Market Drivers:

    Some of the major factors driving the market for Point-Of-Care Testing Market, such as increasing geriatric population, increase in infectious diseases (hepatitis, HIV infection, influenza, respiratory infections and others), technological advancements, introduction of home-based point of care devices, and rapid economic development in the emerging economies. These factors such as increased awareness among the population, ease of use, rapid test, right dosage to the right place, and enhanced patient compliance are also driving the growth for the point-of-care testing market.

    Growing Geriatric Population: Global Point-of-Care Testing Market

    Improved economic growth, better healthcare, and growthin access to education have led to longer life expectancy in most socio-economic groups. Due to growing geriatric population, the cases of acute and chronic diseases are rising. Older population is more prone to diseases such as diabetes, infections, cardiometabolic risks and cancer. The normal aging process causes a variety of physical and emotional issues that can be difficult for both the geriatric patient and healthcare worker to understand their needs and be sensitive in their treatment
    Advancement In Technology : Global Point-of-Care Testing Market

    POCT technologies are evolving, and this market segment is growing at a rapid pace. The use of POCT has evolved further since 2013, with high range of professional and self-monitoring tests into the ambulatory setting with a patient centric focus.. The need to improve patient safety and outcomes through rapid testing with trustworthy and actionable results at the point of care has provided significant benefits, including the ability to provide immediate and appropriate medical intervention. A continuous effort and progress has been made by manufacturers to create products with newer, advanced technologies with reduced sample volume or less blood on portable devices

    Decentralized Laboratory Testing : Global Point-of-Care Testing Market

    For decentralized lab testing, there are two drivers i.e., need for better drug monitoring for diseases like cancer and increasing virulence of infectious diseases. Molecular testing for hospital acquired infections has risen over the last several years so as to reduce cost and length of stay (LOS). Most of the molecular diagnostic tests are carried out in large reference lab or in CLIA-accredited labs but due to more availability of molecular diagnostic tests (specifically for conditions giving a quick result) decentralized labs ora push towards decentralized testing and near-patient settings are seen as a feasible and growing market

    Questions? We’ll Put You On The Right Path Request Analyst Call for Global Point-of-Care Testing (POCT) Market Report Visit @ http://databridgemarketresearch.com/speak-to-analyst/?dbmr=point-care-testing-poct-market

    Market Segmentation:

    Global Point-of-care Testing (POCT) Market By Product (Blood Glucose Testing Kits, Cardiometabolic Monitoring Kits, Infectious Disease Testing Kits, Cholesterol Testing Kits, Pregnancy & Fertility Tests Kits, Tumor/Cancer Markers, Urinalysis Testing Kits, Cholesterol Test Strips, Hematology Testing Kits, Drugs Of Abuse Testing Kits, Fecal Occult Testing Kits, Rapid Coagulation Testing Kits, & Others),By Prescription Mode (Prescription Based Testing & Over-The-Counter Testing),By Distribution Channel (Direct Tenders & Retail),By End User (Hospital, Clinics, Ambulatory Care, Home Healthcare, & Research Laboratory), By Geography (North America, Europe, Asia-Pacific, South America, Rest of the World) – Trends and Forecast to 2024.

    Market Big Players:

    The global point-of-care market is highly concentrated to a few big players and rest to local players who cater to domestic markets only. F. Hoffmann-La Roche Ltd dominated the point-of-care market accounting for a highest market share in 2016, followed by Siemens AG and Abbott. Other players in this market include Beckman Coulter, Inc., Becton, Dickinson and Company, Johnson & Johnson, Alere Inc., Instrumentation Laboratory, PTS Diagnostics, Abaxis, Inc., Medtronic, Accriva Diagnostics, OPTI Medical, Sienco, Inc., Alpha Scientific, AccuBioTech Co., Ltd., ACON Laboratories, Inc., Acrongenomics, Inc, bioMérieux SA, Biomerica, Inc., Atlas Genetics Ltd., Alfa Scientific Designs, Inc., Bio-Rad Laboratories, Inc., Medica Corporation, and Nova Biomedica among others holds 53.1% of the global injectable drug delivery market in 2016.

    Any specific requirements are you looking for? Ask to your Industry Experts @ http://databridgemarketresearch.com/inquire-before-buying/?dbmr=point-care-testing-poct-market

    HOFFMANN-LA ROCHE LTD:

    Historical Background – Roche was established in 1896
    Nature of Business: F. Hoffmann-La Roche Ltd., is one of the largest biotech company with 17 biopharmaceuticals on the market. The company is operating in more than 100 countries around the globe. Some of the subsidiaries are Genetech, Roche Diagnostics, Chugai Pharmaceutical Co., Ventana Medical Systems, InterMune, Inc., Syntex, Anadys Pharmaceuticals, Roche Applied Science, Bioveris, Roche products, Inc., Roche pharma AG, Pt Roche Indonesia, Bina Technologies, Inc., nv Roche sa, Roche SAS, Roche Glycart AG, Roche Co., Ltd.
    Main focus: Since the establishment in 1896, the company’s main focus is on oncology, immunology, ophthalmology, infectious diseases and neuroscience.
    Main Business Areas: Pharmaceuticals and Diagnostics.

    Recent Developments:
    1. In August 2016,Roche Diagnostics Ltd., received FDA approval for cobas Influenza A/B & RSV test for the cobasLiat System that differentiates flu and Respiratory Syncytial Virus (RSV) in 20 minutes
    2. In May 2015, Roche Diagnostics Ltd., received FDA CLIA Waiver for the cobasLiat PCR System and Strep A assay to test Strep A in throat swab specimen.
    3. In December 2014, Roche Diagnostics Ltd, received FDA approval for LightMix Ebola Zaire rRT-PCR Test at the time of emergency to treat Ebola Zaire virus infection.

    Looking for more insights from this report? click the link below @ http://databridgemarketresearch.com/reports/point-care-testing-poct-market/

    TABLE OF CONTENTS GLOBAL POINT-OF-CARE TESTING MARKET

    1. INTRODUCTION

    1.1. OBJECTIVES OF THE STUDY
    1.2. MARKET DEFINITION
    1.3. OVERVIEW OF GLOBAL POINT-OF-CARE TESTING MARKET
    1.4. CURRENCY AND PRICING
    1.5. LIMITATION
    1.6. MARKETS COVERED

    2. MARKET SEGMENTATION

    2.1. MARKETS COVERED
    2.2. GEOGRAPHIC SCOPE
    2.3. YEARS CONSIDERED FOR THE STUDY
    2.4. CURRENCY AND PRICING
    2.5. RESEARCH METHODOLOGY
    2.6. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
    2.7. SECONDARY SOURC
    2.8. ASSUMPTIONS

    3. MARKET OVERVIEW

    3.1. DRIVERS

    3.1.1. GROWING GERIATRIC POPULATION
    3.1.2. ADVANCEMENT IN TECHNOLOGY
    3.1.3. DECENTRALIZED LABORATORY TESTING
    3.1.4. INCREASED INCIDENCE OF CHRONIC DISEASES
    3.1.5. LABORATORY STAFF SHORTAGES

    3.2. RESTRAINTS

    3.2.1. UNFAVOURABLE REIMBURSEMENT SCENARIO
    3.2.2. ECONOMIC COST

    3.3. OPPORTUNITIES

    3.3.1. EMERGING MICROFLUIDIC LAB-ON-A-CHIP TECHNOLOGY
    3.3.2. EMERGING MARKETS
    3.3.3. UNMET MEDICAL NEEDS

    3.4. CHALLENGES

    3.4.1. LACK OF ACCURACY AND EFFICIENCY
    3.4.2. DATA MANAGEMENT AND LACK OF CONNECTIVITY
    3.4.3. TESTING PERFORMED BY NON-LABORATORY PERSONNEL AND LACK OF AWARENESS AMONG THE USERS

    4. EXECUTIVE SUMMARY

    5. PREMIUM INSIGHTS

    6. GLOBAL POINT-OF-CARE TESTING MARKET: REGULATORY SCENARIO

    6.1. OVERVIEW:

    6.1.1. REGULATORY PROCEDURE:

    7. GLOBAL POINT-OF-CARE TESTING MARKET: REIMBURSEMENT SCENARIO

    7.1. OVERVIEW:

    8. GLOBAL POINT-OF-CARE TESTING MARKET, BY PRODUCT TYPE

    8.1. OVERVIEW

    8.2. CARDIOMETABOLIC MONITORING KITS

    8.2.1. CARDIAC MARKERS
    8.2.2. BLOOD GAS ELECTROLYTE TESTING KITS
    8.2.3. HBA1C TESTING KITS
    8.2.4. LIPID TESTING KITS

    8.3. INFECTIOUS DISEASE TESTING KITS

    8.3.1. INFLUENZA TESTING KITS
    8.3.2. HIV TESTING KITS
    8.3.3. HEPATITIS TESTING KITS
    8.3.4. STD TESTING KITS
    8.3.5. TROPICAL DISEASESTESTING KITS
    8.3.6. HEALTHCARE ASSOCIATED TESTING KITS
    8.3.7. RESPIRATORY INFECTIONS TESTING KITS

    8.4. CHOLESTEROL TESTING KITS

    8.4.1. PROTHROMBIN TIME TESTING KITS
    8.4.2. ACTIVATED CLOTTING TIME TESTING KITS

    8.5. BLOOD GLUCOSE TESTING KITS

    8.6. PREGNANCY AND FERTILITY TESTING KITS

    8.7. TUMOR CANCER MARKERS

    8.8. URINALYSIS TESTING KITS

    8.9. HEMATOLOGY TESTING KITS

    8.10. DRUGS OF ABUSE TESTING KITS

    8.11. FECAL OCCULT TESTING KITS

    8.12. RAPID COAGULATION TESTING KITS

    9. GLOBAL POINT-OF-CARE TESTING MARKET, BY DISTRIBUTION CHANNEL

    9.1. OVERVIEW

    9.1.1. DIRECT TENDER
    9.1.2. RETAIL PHARMACY

    10. GLOBAL POINT-OF-CARE TESTING MARKET, BY END USER

    10.1. OVERVIEW
    10.2. GLOBAL POCT MARKET: HOSPITALS
    10.3. GLOBAL POCT MARKET: CLINICS
    10.4. GLOBAL POCT MARKET: AMBULATORY CARE
    10.5. GLOBAL POCT MARKET: HOME HEALTHCARE
    10.6. GLOBAL POCT MARKET: RESEARCH LABORATORIES

    11. GLOBAL POINT-OF-CARE TESTING MARKET, BY PRESCRIPTION MODE

    11.1. OVERVIEW
    11.2. GLOBAL POCT MARKET: PRESCRIPTION BASED TESTING KITS
    11.3. GLOBAL POCT MARKET: OVER THE COUNTER BASED TESTING KITS

    12. GLOBAL POINT-OF-CARE TESTING MARKET, BY GEOGRAPHY

    12.1. OVERVIEW

    12.2. NORTH AMERICA POINT-OF-CARE TESTING MARKET

    12.2.1. U.S.POINT-OF-CARE TESTING MARKET
    12.2.2. CANADA POINT-OF-CARE TESTING MARKET
    12.2.3. MEXICO POINT-OF-CARE TESTING MARKET

    12.3. EUROPE POINT-OF-CARE TESTING MARKET

    12.3.1. GERMANY POINT-OF-CARE TESTING MARKET
    12.3.2. FRANCE POINT-OF-CARE TESTING MARKET
    12.3.3. U.K. POINT-OF-CARE TESTING MARKET
    12.3.4. ITALY POINT-OF-CARE TESTING MARKET
    12.3.5. SPAIN POINT-OF-CARE TESTING MARKET
    12.3.6. RUSSIA POINT-OF-CARE TESTING MARKET
    12.3.7. TURKEY POINT-OF-CARE TESTING MARKET
    12.3.8. BELGIUM POINT-OF-CARE TESTING MARKET
    12.3.9. NETHERLANDS POINT-OF-CARE TESTING MARKET
    12.3.10. SWITZERLAND POINT-OF-CARE TESTING MARKET
    12.3.11. REST OF EUROPE POINT-OF-CARE TESTING MARKET

    12.4. APAC POINT-OF-CARE TESTING MARKET

    12.4.1. JAPAN POINT-OF-CARE TESTING MARKET
    12.4.2. CHINA POINT-OF-CARE TESTING MARKET
    12.4.3. SOUTH KOREA POINT-OF-CARE TESTING MARKET
    12.4.4. INDIA POINT-OF-CARE TESTING MARKET
    12.4.5. AUSTRALIA POINT-OF-CARE TESTING MARKET
    12.4.6. SINGAPORE POINT-OF-CARE TESTING MARKET
    12.4.7. THAILAND POINT-OF-CARE TESTING MARKET
    12.4.8. MALAYSIA POINT-OF-CARE TESTING MARKET
    12.4.9. INDONESIA POINT-OF-CARE TESTING MARKET
    12.4.10. PHILIPPINES POINT-OF-CARE TESTING MARKET
    12.4.11. REST OF APAC POINT-OF-CARE TESTING MARKET

    12.5. MEA POINT-OF-CARE TESTING MARKET

    12.5.1. SOUTH AFRICA POINT-OF-CARE TESTING MARKET
    12.5.2. SAUDI ARABIA POINT-OF-CARE TESTING MARKET
    12.5.3. UAE POINT-OF-CARE TESTING MARKET
    12.5.4. REST OF MEA POINT-OF-CARE TESTING MARKET

    12.6. SOUTH AMERICA POINT-OF-CARE TESTING MARKET

    12.6.1. BRAZIL POINT-OF-CARE TESTING MARKET

    13. GLOBAL POINT-OF-CARE TESTING MARKET : COMPANY LANDSCAPE

    13.1. COMPANY SHARE ANALYSIS: GLOBAL
    13.2. COMPANY SHARE ANALYSIS: NORTH AMERICA
    13.3. COMPANY SHARE ANALYSIS: EUROPE
    13.4. COMPANY SHARE ANALYSIS: APAC

    14. COMPANY PROFILES
    14.1. JOHNSON AND JOHNSON SERVICES, INC.
    14.2. BECTON, DICKINSON AND COMPANY
    14.3. MEDTRONIC
    14.4. F. HOFFMANN-LA ROCHE LTD
    14.5. SIEMENS AG
    14.6. ABBOTT
    14.7. DANAHER
    14.8. WERFENLIFE
    14.9. HENRY SCHEIN, INC.
    14.10. OPTI MEDICAL (SUBSIDIARY OF IDEXX LABORATORIES, INC)
    14.11. SIENCO, INC.
    14.12. ACON LABORATORIES, INC.
    14.13. ATIVA MEDICAL CORPORATION
    14.14. ABAXIS
    14.15. ARKRAY, INC
    14.16. AERSCHER DIAGNOSTICS, LLC
    14.17. ARTRON LABORATORIES, INC.
    14.18. BIOMERIEUX SA
    14.19. ENTOPSIS

    15. RELATED REPORTS

    Browse Detailed TOC, Tables and Figures @ http://databridgemarketresearch.com/toc/?dbmr=point-care-testing-poct-market

    Related Report

    Europe POCT Device Market – Trends and Forecast To 2024
    Europe Point-of-care Testing (POCT) Market, By Product (Blood Glucose Testing Kits, Cardiometabolic Monitoring Kits, Infectious Disease Testing Kits, Cholesterol Testing Kits, Pregnancy & Fertility Tests Kits, Tumor/Cancer Markers, Urinalysis Testing Kits, Cholesterol Test Strips, Hematology Testing Kits, Drugs Of Abuse Testing Kits, Fecal Occult Testing Kits, Rapid Coagulation Testing Kits), Prescription Mode (Prescription, OTC), Distribution Channel, End User, Country – Trends and Forecast to 2024

    Report Access: http://databridgemarketresearch.com/reports/europe-poct-device-market/

    About Data Bridge Market Research:

    Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

    Contact:
    Vishal Dixit
    Data Bridge Market Research
    Tel: +1-888-387-2818
    Email: sopan.gedam@databridgemarketresearch.com



    Data Bridge Market Resea
    +1-888-387-2818
    sopan.gedam@databridgemarketresearch.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, May 09, 2018 ) Newly added Report of “Global Revenue Cycle Management Market” has accounted to USD 51.6 billion in 2016, growing at a CAGR of 12.7% from 2017 to 2024, is expected to reach USD 133.6 billion by 2024.

    Competitive Analysis:

    In the components sub-category of the RCM market, the services segment dominates the market, and is expected to reach $50.9 billion by 2022. Similarly, in the deployments sub-category of the market, the web-based segment dominates the market, and is expected account a market share of 43.1% of the global RCM market. The physicians segment dominates the market among end-users, and is accounted to $21.1billion in 2015.

    Click Here for Free Sample Report @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-revenue-cycle-management-rcm-market

    Revenue cycle management (RCM) is used by healthcare providers to scale and manage the process of healthcare billing and reimbursements. This is achieved by improving the process of claims management, speeding explanation of benefits (EOB) reconciliation, improving the quality of information, streamlining denial management, and by automating processes. The RCM solution manages the patient’s bills from entering the hospital to reimbursement of claims.

    TABLE OF CONTENTS

    1 INTRODUCTION
    1.1. OVERVIEW OF THE GLOBAL PROTEIN REVENUE CYCLE MANAGEMENT MARKET
    1.2. CURRENCY AND PRICING
    1.3. LIMITATION
    1.4. MARKETS COVERED
    2 MARKET SEGMENTATION
    2.1. KEY TAKEAWAYS
    2.2. ARRIVING AT THE GLOBAL PROTEIN REVENUE CYCLE MANAGEMENT SIZE
    2.2.1 VENDOR POSITIONING GRID
    2.2.2 TECHNOLOGY LIFE LINE CURVE
    2.2.3 MARKET TIME LINE
    2.2.4 MARKET GUIDE
    2.2.5 COMPANY POSITIONING GRID
    2.2.6 COMAPANY MARKET SHARE ANALYSIS
    2.2.7 MULTIVARIATE MODELLING
    2.2.8 STANDARDS OF MEASUREMENT
    2.2.9 TOP TO BOTTOM ANALYSIS
    2.2.10 VENDOR SHARE ANALYSIS
    2.2.11 DATA POINTS FROM KEY PRIMARY INTERVIEWS
    2.2.12 DATA POINTS FROM KEY SECONDARY DATABASES
    2.3. GLOBAL PROTEIN REVENUE CYCLE MANAGEMENT MARKET: RESEARCH SNAPSHOT
    2.4. ASSUMPTIONS
    3 MARKET OVERVIEW
    3.1. DRIVERS
    3.2. RESTRAINTS
    3.3. OPPORTUNITIES
    3.4. CHALLENGES
    4 EXECUTIVE SUMMARY
    5 PREMIUM INSIGHTS
    5.1. VENDOR POSITIONING GRID AND INVESTMENT OPPORTUNITIES
    5.2. TECHNOLOLGICAL ADVANCEMENTS
    5.3. INSIGHTS ON TECHNOLOGICAL DEVELOPMENTS IN THE GLOBAL SURFACE DISINFECTANTMARKET
    5.4. MARKET REGULATORY SCENARIO BY COUNTRY
    5.5. INTERVIEW KEY INSIGHTS
    6 GLOBAL PROTEIN REVENUE CYCLE MANAGEMENT MARKET, BY TECHNOLOGY
    7 GLOBAL PROTEIN REVENUE CYCLE MANAGEMENT MARKET, BY END USER
    8 GLOBAL PROTEIN REVENUE CYCLE MANAGEMENT MARKET, BY APPLICATIONS
    9 GLOBAL PROTEIN REVENUE CYCLE MANAGEMENT MARKET, BY PROCEDURE
    10 GLOBAL PROTEIN REVENUE CYCLE MANAGEMENT MARKET, BY GEOGRAPHY
    11 GLOBAL PROTEIN REVENUE CYCLE MANAGEMENT MARKET, COMPANY PROFILES
    11.1 THERMO FISHER SCIENTIFIC INC.,
    11.2 BIO-RAD LABORATORIES INC.
    11.3 MERCK MILLIPORE
    11.4 QIAGEN N.V.
    11.5 AGILENT TECHNOLOGIES
    11.6 COMPANY A
    11.7 COMPANY B
    11.8 COMPANY C
    11.9 COMPANY D
    11.10 COMPANY E
    11.11 COMPANY F
    11.12 COMPANY G
    11.13 COMPANY H
    11.14 COMPANY I
    11.15 COMPANY J
    11.16 COMPANY K
    11.17 COMPANY M
    11.18 COMPANY N
    11.19 COMPANY O
    12 APPENDIX
    13 ABOUT DATA BRIDGE MARKET RESEARCH

    Segmentation:

    In this report, the revenue cycle management market is segmented on the basis of product type, deployment, component, stage, end-user, and geography.
    Based on type the market is further segmented into integrated RCM and standalone RCM.
    On the basis of product type RCM solutions are segmented into standalone and integrated RCM. The integrated RCM solution are generally used by larger organizations where integration with other healthcare IT products such as RIS, LIS, PACS, HER among others to form a more holistic process for billing and claim settlements. However standalone RCM is best used in smaller hospitals and physician offices where they need to manage only one healthcare application.
    Based on end-users the market is segmented into hospitals, laboratories, and physicians and others.
    Based on geography the revenue cycle management market report is segmented into 5 geographical regions, North America, Europe, Asia-Pacific, South America and rest of the world. The geographical regions are further segmented into 24 major countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa and many others. U.S. is expected to dominate the market due to the rising need to decrease healthcare expenditure which is forming the major share of the market. With the market in U.S. shifting to value based reimbursements RCM is expected to play a major role to develop this process.

    To Read More About Detail TOC Visit @ http://databridgemarketresearch.com/toc/?dbmr=global-revenue-cycle-management-rcm-market

    Market Key Drivers: Global Revenue Cycle Management (RCM) Market

    The North American revenue cycle management market is steadily progressing owing to factors, such as decreasing reimbursement in healthcare industry, reduction of overall healthcare costs, initiatives undertaken by governments for implementing RCM solutions, and increasing expenditure by healthcare industry especially made on information technology.

    Top Companies:

    • McKesson Corporation
    • Cerner Corporation
    • Quest Diagnostics
    • Athena Health, Inc.
    • Allscripts
    • Eclinicalworks LLC
    • CareCloud Corporation
    • The SSI Groups, Inc.
    • GE Healthcare
    • Epic Systems
    • Siemens Healthcare
    • Kareo, Inc.
    • Among Others

    The North American revenue cycle management market is steadily progressing owing to factors, such as decreasing reimbursement in healthcare industry, reduction of overall healthcare costs, initiatives undertaken by governments for implementing RCM solutions, and increasing expenditure by healthcare industry especially made on information technology.

    Read more about the Global Revenue Cycle Management Market Landscape: http://databridgemarketresearch.com/reports/global-revenue-cycle-management-rcm-market/

    Related Report

    Global Digital Health Monitoring Market – Industry Trends and Forecast to 2024

    Global Digital Health Monitoring Market By Product Type (Devices (Blood Pressure Monitors, Blood Glucose Monitors, ECG, Oximeters, Peak Flow Monitors, Multi Parameter Monitors, Sleep Apnea Monitors, Neurological Monitors, Others), Software (Healthcare Apps, Chronic Disease Apps, Personal Health Apps, Others), Services (Remote Monitoring, Consultancy Services, Treatment Services, Fitness and Wellness Services, Others), By Geography (North America, Europe, Asia Pacific, South America, Middle East & Africa) – Industry Trends and Forecast to 2024

    Report Access: http://databridgemarketresearch.com/reports/global-digital-health-monitoring-devices-market/

    About Data Bridge Market Research:

    Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

    Contact:
    Vishal Dixit
    Data Bridge Market Research
    Tel: +1-888-387-2818
    Email: sopan.gedam@databridgemarketresearch.com
    Investor: investors@databridgemarketresearch.com



    Data Bridge Market Resea
    +1-888-387-2818
    sopan.gedam@databridgemarketresearch.com

    Source: EmailWire.Com

    0 0

    (EMAILWIRE.COM, May 09, 2018 ) Hip & Knee Orthopedic Surgical Implants market is projected to reach more than US$ 12 Billion by 2021, at a CAGR of % from 2016 to 2021. The growing prevalence of symptomatic osteoarthritis and post–traumatic arthritis due to the growing aging segment of the population across the globe will continue to drive growth in the hip & knee orthopedic surgical implants market. Increasing life spans and lifestyles impact the number of individuals with joints subject to failure, thereby increasing demand for hip & knee replacement procedures. Additionally, the growing health awareness among masses, along with increase in the spending capacity of the population are propelling the market growth.

    Order Free sample report@ http://www.researchformarkets.com/sample/global-hip-and-knee-orthopedic-surgical-implants-market-416

    Hip & Knee Orthopedic Surgical Implants Market: Country–wise Outlook
    United States is seen as the dominant player in the hip & knee orthopedic surgical implants market. International markets such as India, China and Japan will show positive growth in the future and market share will increase to XX% by the year 2021. The opportunity is immense in the emerging markets, as there is a large untapped population with hip and knee orthopedic surgical implants need.


    Hip & Knee Orthopedic Surgical Implants Market: Key Players Outlook:
    The global hip & knee orthopedic surgical implants market is dominated by Zimmer Biomet, Stryker, DePuy Synthes and Smith & Nephew. The three large players in the hip & knee orthopedic surgical implants market are Zimmer Biomet, DePuy Synthes and Stryker combined, they comprise almost more than XX% of the market. Other nominal yet important players of this market include, Exactech, DJO Global, Smith & Nephew and many more. It is expected that Zimmer Biomet will emerge as a leading company in the hip & knee orthopedic surgical implants market.

    Scope Of This Report:
    The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry–validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, type of product and deal landscapes. The report concludes with the profiles of major players in the global hip and knee orthopedic surgical implants market such as Zimmer Biomet, Stryker, Smith & Nephew, Exactech, DePuy Synthes. The major market players are evaluated on various parameters such as company overview, product portfolio, and revenue of hip and knee implants from 2008 to 2021.

    The report covers in–depth analysis on:

    • Market Segments
    • Market Dynamics
    • Historical Actual Market Size, 2008 – 2015
    • Market Size & Forecast 2016 to 2021
    • Competition & Companies involved
    • Deals Landscapes
    • Market Growth Drivers and Challenges

    Global Hip & Knee Orthopedic Surgical Implants Market is segmented as follows:

    • Global – Hip & Knee Implants Market & Forecast (2008 – 2021)

    • Global – Hip & Knee Implants Market Share & Forecast (2008 – 2021)

    • Global – Hip Implants Market & Forecast (2008 – 2021)

    • Global – Knee Implants Market & Forecast (2008 – 2021)

    • Global – Hip Implants Market Share & Forecast (2008 – 2021)

    • Company Market Share Outlook

    • Country Market Share Outlook

    • Global – Knee Implants Market Share & Forecast (2008 – 2021)

    • Company Market Share Outlook

    • Country Market Share Outlook

    Global - Hip Implants Market – Country Outlook :

    • United States
    • Germany
    • Italy
    • France
    • Spain
    • United Kingdom
    • Japan
    • Brazil
    • China
    • India

    Global - Knee Implants Market – Country Outlook:

    • United States
    • International


    Global – Hip & Knee Implants Market: Key Company Analysis:

    • Zimmer Biomet
    • Stryker
    • DePuy Synthes (Johnson & Johnson)
    • Smith & Nephew
    • Exactech
    • Other Companies

    Global Hip & Knee Implants Market: Deals Landscape:

    • Merger & Acquisitions
    • Partnerships
    • Collaboration
    • Distribution Agreement

    Reserve Your Instant Discount On This Report@ http://www.researchformarkets.com/discount/global-hip-and-knee-orthopedic-surgical-implants-market-416

    Short Review On Table Of Contains:
    1. Executive Summary

    2. Global – Knee Implants Market & Forecast

    3. Global – Knee Implants Market Share & Forecast
    3.1 Global – Knee Implants Market Share & Forecast – Company Outlook
    3.2 Global – Knee Implants Market Share & Forecast – Country Outlook

    4. Global Knee Implants Market – Country Outlook & Forecast
    4.1 United States – Knee Implants Market Analysis & Forecast
    4.2 International – Knee Implants Market Analysis & Forecast

    5. Global – Knee Implants Market: Key Company Analysis
    5.1 Zimmer Biomet
    5.1.1 Business Overview
    5.1.2 Knee Implants Products
    5.1.3 Knee Implants Revenue Analysis & Forecast (2008 – 2021)
    5.2 Stryker
    5.2.1 Business Overview
    5.2.2 Knee Implants Products
    5.2.3 Knee Implants Revenue Analysis & Forecast (2008 – 2021)
    5.3 Smith & Nephew
    5.3.1 Business Overview
    5.3.2 Knee Implants Products
    5.3.3 Knee Implants Revenue Analysis & Forecast (2008 – 2021)
    5.4 Exactech
    5.4.1 Business Overview
    5.4.2 Knee Implants Products
    5.4.3 Knee Implants Revenue Analysis & Forecast (2008 – 2021)
    5.5 DePuy Synthes (Johnson & Johnson)
    5.5.1 Business Overview
    5.5.2 Knee Implants Products
    5.5.3 Knee Implants Revenue Analysis & Forecast (2008–2021)
    5.6 Other Companies
    5.6.1 Knee Implants Revenue Analysis & Forecast (2008–2021)

    6. Global Knee Implants Market: Deals Landscape
    6.1 Knee Implants Market – Merger & Acquisitions
    6.2 Knee Implants Market – Partnerships, Collaboration & Distribution Agreement

    7. Knee Implants Market – Growth Drivers
    7.1 Developing Markets Boon for the Manufacturers to Upsurge the Growth
    7.2 Ageing Population & Life Expectancy Boost Growth for the Knee Implants Market

    8. Knee Implants Market – Challenges
    8.1 Fail to Introduce New Products & Continual Development May Lost the Competition
    8.2 Reliance on Government and Other Funding by the Manufacturers Impede the Market Growth
    8.3 World Economic Conditions – A Setback for the Market Growth
    8.4 Political Uncertainties
    8.5 Regulatory Standards and Compliance in the Medical Device Industry

    Continue….

    Study More About This Report@ http://www.researchformarkets.com/reports/global-hip-and-knee-orthopedic-surgical-implants-market-416

    About Us:
    Research for Markets indulges in detailed and diligent research on different markets, trends and emerging opportunities in the successive direction to cater to your business needs. We have established the pillars of our flourishing institute on the grounds of Credibility and Reliability. RFM delve into the markets across Asia Pacific, North America, South America, Europe, Middle East and Africa.
    Our purpose is to serve you, the most customized in-depth Market access data. Our plethora of titles made us one of the most searched market research library across the globe. We work with the most esteemed Publishers around the globe who caters vast industries. We are quick and fragile, when it comes to your various queries, and we ensure our team caters your needs to the best of our abilities, we promise to stay by your side for both pre and post sales servicing, as we believe in long everlasting symbiotic relationship.

    Contact Us:
    Mr. A Naidu
    RESEARCH FOR MARKETS
    Email: alan.naidu@researchformarkets.com
    Direct Contact: +44 8000-4182-37 (Toll Free)



    Data Bridge Market Resea
    +1-888-387-2818
    sopan.gedam@databridgemarketresearch.com

    Source: EmailWire.Com

    0 0

    (EMAILWIRE.COM, May 09, 2018 ) The Pharmaceutical Propellant is segmented by type into Liquid Gas Propellant and Compressed Gas Propellant. In this segment, Liquid Gas Propellant segment is projected to grow at remarkable pace over the forecast period.  Further, Liquid Gas Propellant segment is sub-segmented into Hydrocarbons, Chlorofluro Carbons, Hydrofluro Carbons, and Hydro Chloro Fluro Carbons. Increasing research and development activities in pharmaceutical is expected to showcase a significant rise in the growth of pharmaceutical propellant market over the forecast period.

    Global Pharmaceutical Propellant market is expected to register a considerable CAGR over the forecast period. Moreover, propellant market is rising on the back of the advancement and expansion of the pharmaceutical industry. Increasing skin and nasal diseases among population is expected to garner the growth of pharmaceutical propellant market

    In term of region, North America captured maximum share of the pharmaceutical propellant market by 2017. Further Research activities in pharmaceutical industry are expected to drive the growth of the pharmaceutical propellant market over the forecast period. Europe is expected to contribute significantly towards the growth of the pharmaceutical propellant market. Apart from this increasing spending money and high awareness is anticipated to robust the growth of pharmaceutical propellant market.

    Increasing Various Type of Nasal & Skin Diseases

    As pollution increases different type of skin & nasal diseases are cause among the population. With the help of propellant drug can be deliver at the infected part of the human body directly which is more effective as to consume drug orally. This factor is expected to positively impact growth of the pharmaceutical propellant market over the forecast period.

    Request Free Sample Report @ https://www.researchnester.com/sample-request-1065

    Increasing Research & Development Activities in Pharmaceutical

    Increasing interest of researchers and investing companies towards pharmaceutical propellant is anticipated to be the dynamic factor behind the growth of pharmaceutical propellant market across the global. The market is mainly expanding on the back of the growth and expansion of pharmaceutical industry and high awareness related to health among population. High prevalence of the nasal disease and skin problem cause of the environment changes is expected to benefits the growth of pharmaceutical propellant market.

    The report titled “ Global Pharmaceutical Propellant Market: Global Historical Growth (2012-2017) & Future Outlook (2018-2027) Demand Analysis & Opportunity Evaluation” delivers detailed overview of the global pharmaceutical propellant market in terms of market segmentation by Typ, by end user and by region.

    Further, for the in-depth analysis, the report encompasses the industry growth drivers, restraints, supply and demand risk, market attractiveness, BPS analysis and Porter’s five force model.

    Request Table Of Content @ https://www.researchnester.com/request-toc-1065

    This report also provides the existing competitive scenario of some of the key players of the global data as a service market which includes company profiling of Cayman Chemical. Derex Labs Pvt  Ltd, Shaanxi Yuanyu Biological, Toronto Research ChemicalS In,   Hangzhou Meite ChemicalWilshire TechnologiesX´ian Taicheng ChemCapot Chemical Manus Aktteva Biopharma, Aphios. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global data as a service market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.

    To Know More About This Report @ https://www.researchnester.com/reports/pharmaceutical-propellants-market/1065

    About Us:-

    Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision so as to avoid future uncertainties.

    Contact for more Info:

    Ajay Daniel

    Email: ajay.daniel@researchnester.com

    U.S. Phone: +1 646 586 9123

    U.K. Phone: +44 203 608 5919


    Ajay Daniel
    +1 6465869123
    news@researchnester.com

    Source: EmailWire.Com

    0 0

    (EMAILWIRE.COM, May 09, 2018 ) Singapore
    A global report titled Ceramic Membrane Market has been introduced into our library of 2.5 million reports.

    About the market report:
    Ceramic Membrane market research report provides the newest industry data and industry future trends, allowing you to identify the products and end users driving revenue growth and profitability. 
    The industry report lists the leading competitors and provides the insights strategic industry analysis of the key factors influencing the market.
    The report includes the forecasts, analysis and discussion of important industry trends, market size, market share estimates and profiles of the leading industry players.

    The market is expected to expand at 5.8% CAGR over the period between 2016 and 2021.

    To access the full table of contents of the report click below:https://www.marketintelreports.com/report/icrw0852/world-ceramic-membrane-market-research-report-2021-covering-usa-eu-china-south-east-asia-japan-and-etc


    Global Ceramic Membrane Market: Product Segment Analysis
    Microfiltration
    ultrafiltration
    others
    Global Ceramic Membrane Market: Application Segment Analysis
    Chemical industry
    Metal industry / Surface engineering
    Textiles / Pulp and paper industry
    Food and beverages
    Recycling and environment
    others

    Global Ceramic Membrane Market: Regional Segment Analysis
    USA
    Europe
    Japan
    China
    India
    South East Asia

    There are 10 Chapters to deeply display the global Ceramic Membrane market.

    To find out more of the report or request some customization:https://www.marketintelreports.com/inquiry-before-buying.php?id=icrw0852

    Table of Contents-Key Points Covered
    Chapter 1 About the Ceramic Membrane Industry
    1.1 Industry Definition
    1.1.1 Types of Ceramic Membrane industry
    1.2.1.1 Microfiltration
    1.2.1.2 ultrafiltration
    1.2.1.3 others
    1.2 Main Market Activities
    1.3 Similar Industries
    1.4 Industry at a Glance

    ………….
    Chapter 6 Globalisation & Trade
    6.1 Business Locations
    6.2 Supply channels
    6.3 Marketing strategy
    6.4 Barriers to Entry
    Chapter 7 Distributors and Customers
    7.1 Major Distributors and contact information by regions
    7.2 Major Customers and contact information by regions
    Continued…..

    Complete Report Details @https://www.marketintelreports.com/report/icrw0852/world-ceramic-membrane-market-research-report-2021-covering-usa-eu-china-south-east-asia-japan-and-etc


    About us:
    MIR intends to be a one-stop shop with an intuitive design, exhaustive database, expert assistance, secure cart checkout and data privacy integrated. It curates the list of reports, publishers and studies to ensure that the database is constantly updated to dynamically meet the targeted, specific needs of our clients.
    MarketIntelReports currently has more than 2.5 million titles and 200 publishers on our platform and are growing consistently to fill the “World Intelligence Demand – Supply Gap”. We cover more than 15 industry verticals being: Automotive, Electronics, Manufacturing, Pharmaceuticals, Healthcare, Chemicals, Building & Construction, Agriculture, Food & Beverages, Banking & Finance, Media and Government, Public Sector Studies.


    Lakshmi
    1-302-261-5343
    sales@marketintelreports.com

    Source: EmailWire.Com

    0 0

    (EMAILWIRE.COM, May 09, 2018 ) Singapore
    A global report titled Lithium Ion Battery Market has been introduced into our library of 2.5 million reports.

    About the market report:
    A lithium-ion battery (sometimes Li-ion battery or LIB) is a member of a family of rechargeable battery types in which lithium ions move from the anode to the cathode during discharge and back when charging. Li-ion batteries use an intercalated lithium compound as the electrode material, compared to the metallic lithium used in non-rechargeable lithium battery.
    Lithium Ion Battery market research report provides the newest industry data and industry future trends, allowing you to identify the products and end users driving Revenue growth and profitability. 
    The industry report lists the leading competitors and provides the insights strategic industry Analysis of the key factors influencing the market.
    The report includes the forecasts, Analysis and discussion of important industry trends, market size, market share estimates and profiles of the leading industry Players.
    The market is expected to expand at 15.17% CAGR over the period between 2016 and 2021.

    To access the full table of contents of the report click below:https://www.marketintelreports.com/report/icrw0860/world-lithium-ion-battery-market-research-report-2021covering-usa-eu-china-south-east-asia-japan-and-etc


    Global Lithium Ion Battery Market: Product Segment Analysis
    Prismatic Lithium Ion Battery
    Cylindrical Lithium Ion Battery
    Other

    Global Lithium Ion Battery Market: Application Segment Analysis
    Consumer electronics
    Automotive
    Other

    Global Lithium Ion Battery Market: Regional Segment Analysis
    USA
    Europe
    Japan
    China
    India
    South East Asia

    There are 10 Chapters to deeply display the global Lithium Ion Battery market.

    To find out more of the report or request some customization:https://www.marketintelreports.com/inquiry-before-buying.php?id=icrw0860

    Table of Contents-Key Points Covered
    Chapter 1 About the Lithium Ion Battery Industry
    1.1 Industry Definition
    1.1.1 Types of Lithium Ion Battery industry
    1.1.1.1 Prismatic Lithium Ion Battery
    1.1.1.2 Cylindrical Lithium Ion Battery
    1.1.1.3 Other
    1.2 Main Market Activities
    1.3 Similar Industries
    1.4 Industry at a Glance
    ………….
    Chapter 6 Globalisation & Trade
    6.1 Business Locations
    6.2 Supply channels
    6.3 Marketing strategy
    6.4 Barriers to Entry
    Chapter 7 Distributors and Customers
    7.1 Major Distributors and contact information by Regions
    7.2 Major Customers and contact information by Regions
    Chapter 8 Import, Export, Consumption and Consumption Value by Major Countries
    8.1 USA
    8.2 Germany
    8.3 China
    8.4 Japan
    8.5 India
    8.6 South East Asia
    Continued…..

    Complete Report Details @ https://www.marketintelreports.com/report/icrw0860/world-lithium-ion-battery-market-research-report-2021covering-usa-eu-china-south-east-asia-japan-and-etc


    About us:
    MIR intends to be a one-stop shop with an intuitive design, exhaustive database, expert assistance, secure cart checkout and data privacy integrated. It curates the list of reports, publishers and studies to ensure that the database is constantly updated to dynamically meet the targeted, specific needs of our clients.
    MarketIntelReports currently has more than 2.5 million titles and 200 publishers on our platform and are growing consistently to fill the “World Intelligence Demand – Supply Gap”. We cover more than 15 industry verticals being: Automotive, Electronics, Manufacturing, Pharmaceuticals, Healthcare, Chemicals, Building & Construction, Agriculture, Food & Beverages, Banking & Finance, Media and Government, Public Sector Studies.


    Lakshmi
    1-302-261-5343
    sales@marketintelreports.com

    Source: EmailWire.Com

    0 0

    (EMAILWIRE.COM, May 09, 2018 ) Singapore
    A global report titled Microfiltration Membrane Market has been introduced into our library of 2.5 million reports

    About the market report:
    Microfiltration Membrane market research report provides the newest industry data and industry future trends, allowing you to identify the products and end users driving revenue growth and profitability. 
    The industry report lists the leading competitors and provides the insights strategic industry analysis of the key factors influencing the market.
    The report includes the forecasts, analysis and discussion of important industry trends, market size, market share estimates and profiles of the leading industry players.
    The market is expected to expand at 7.62% CAGR over the period between 2016 and 2021.

    To access the full table of contents of the report click below:https://www.marketintelreports.com/report/icrw0861/world-microfiltration-membrane-market-research-report-2021-covering-usa-eu-china-south-east-asia-japan-and-etc


    Global Microfiltration Membrane Market: Product Segment Analysis
    PVDF
    PTFE
    PES
    other related materials

    Global Microfiltration Membrane Market: Application Segment Analysis
    Industrial/wastewater Treatment
    Dairy pharmaceuticals
    Oil & petrochemical
    others

    Global Microfiltration Membrane Market: Regional Segment Analysis
    USA
    Europe
    Japan
    China
    India
    South East Asia
    The players mentioned in our report
    Asahi Kasei
    Toray
    KMS
    GE Water & Process Technologies
    Toyobo
    KUBOTA

    There are 10 Chapters to deeply display the global Microfiltration Membrane market.

    To find out more of the report or request some customization:https://www.marketintelreports.com/inquiry-before-buying.php?id=icrw0861

    Table of Contents-Key Points Covered
    Chapter 1 About the Microfiltration Membrane Industry
    1.1 Industry Definition
    1.1.1 Types of Microfiltration Membrane industry
    1.2.1.1 PVDF
    1.2.1.2 PTFE
    1.2.1.3 PES
    1.2.1.4 other related materials
    1.2 Main Market Activities
    1.3 Similar Industries
    1.4 Industry at a Glance
    ………….
    Chapter 6 Globalisation & Trade
    6.1 Business Locations
    6.2 Supply channels
    6.3 Marketing strategy
    6.4 Barriers to Entry
    Chapter 7 Distributors and Customers
    7.1 Major Distributors and contact information by regions
    7.2 Major Customers and contact information by regions
    Chapter 8 Import, Export, Consumption and Consumption Value by Major Countries
    8.1 USA
    8.2 Germany
    8.3 China
    8.4 Japan
    8.5 India
    8.6 South East Asia
    Continued…..

    Complete Report Details @ https://www.marketintelreports.com/report/icrw0861/world-microfiltration-membrane-market-research-report-2021-covering-usa-eu-china-south-east-asia-japan-and-etc


    About us:
    MIR intends to be a one-stop shop with an intuitive design, exhaustive database, expert assistance, secure cart checkout and data privacy integrated. It curates the list of reports, publishers and studies to ensure that the database is constantly updated to dynamically meet the targeted, specific needs of our clients.
    MarketIntelReports currently has more than 2.5 million titles and 200 publishers on our platform and are growing consistently to fill the “World Intelligence Demand – Supply Gap”. We cover more than 15 industry verticals being: Automotive, Electronics, Manufacturing, Pharmaceuticals, Healthcare, Chemicals, Building & Construction, Agriculture, Food & Beverages, Banking & Finance, Media and Government, Public Sector Studies.


    Lakshmi
    1-302-261-5343
    sales@marketintelreports.com

    Source: EmailWire.Com

    0 0

    (EMAILWIRE.COM, May 09, 2018 ) Singapore
    A global report titled Reverse Osmosis Membrane Market has been introduced into our library of 2.5 million reports.

    About the market report:
    Reverse Osmosis Membrane market research report provides the newest industry data and industry future trends, allowing you to identify the products and end users driving Revenue (M USD) growth and profitability. 
    The industry report lists the leading competitors and provides the insights strategic industry Analysis of the key factors influencing the market.
    The report includes the forecasts, Analysis and discussion of important industry trends, market size, market share estimates and profiles of the leading industry Players.

    The market is expected to expand at 8.93% CAGR over the period between 2016 and 2021.


    To access the full table of contents of the report click below:https://www.marketintelreports.com/report/icrw0866/world-reverse-osmosis-membrane-market-research-report-2021covering-usa-eu-china-south-east-asia-japan-and-etc



    Global Reverse Osmosis Membrane Market: Product Segment Analysis
    Asymmetric Reverse Osmosis Membrane
    Composite Reverse Osmosis Membrane
    Global Reverse Osmosis Membrane Market: Application Segment Analysis
    Seawater desalination, brackish water desalination
    Pure water production
    Industrial wastewater treatment
    Industrial boiler water supply
    Other applications
    Global Reverse Osmosis Membrane Market: Regional Segment Analysis
    USA
    Europe
    Japan
    China
    India
    South East Asia

    There are 10 Chapters to deeply display the global Reverse Osmosis Membrane market.

    To find out more of the report or request some customization:https://www.marketintelreports.com/inquiry-before-buying.php?id=icrw0866

    Table of Contents-Key Points Covered
    Chapter 1 About the Reverse Osmosis Membrane Industry
    1.1 Industry Definition
    1.1.1 Types of Reverse Osmosis Membrane industry
    1.1.1.1 Asymmetric Reverse Osmosis Membrane
    1.1.1.2 Composite Reverse Osmosis Membrane
    1.2 Main Market Activities
    1.3 Similar Industries
    1.4 Industry at a Glance
    ………….
    Chapter 6 Globalisation & Trade
    6.1 Business Locations
    6.2 Supply channels
    6.3 Marketing strategy
    6.4 Barriers to Entry
    Chapter 7 Distributors and Customers
    7.1 Major Distributors and contact information by Regions
    7.2 Major Customers and contact information by Regions
    Chapter 8 Import, Export, Consumption and Consumption Value by Major Countries
    8.1 USA
    8.2 Germany
    8.3 China
    8.4 Japan
    8.5 India
    8.6 South East Asia
    Continued…..
    Complete Report Details @https://www.marketintelreports.com/report/icrw0866/world-reverse-osmosis-membrane-market-research-report-2021covering-usa-eu-china-south-east-asia-japan-and-etc


    About us:
    MIR intends to be a one-stop shop with an intuitive design, exhaustive database, expert assistance, secure cart checkout and data privacy integrated. It curates the list of reports, publishers and studies to ensure that the database is constantly updated to dynamically meet the targeted, specific needs of our clients.
    MarketIntelReports currently has more than 2.5 million titles and 200 publishers on our platform and are growing consistently to fill the “World Intelligence Demand – Supply Gap”. We cover more than 15 industry verticals being: Automotive, Electronics, Manufacturing, Pharmaceuticals, Healthcare, Chemicals, Building & Construction, Agriculture, Food & Beverages, Banking & Finance, Media and Government, Public Sector Studies.


    Lakshmi
    1-302-261-5343
    sales@marketintelreports.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, May 09, 2018 ) Publisher’s latest report," Evolving Pharmaceutical Marketing Strategies : Digital as a Key Component of Multichannel Marketing" provides a comprehensive analysis of the changing pharmaceutical marketing landscape in the digital age.

    While the pharmaceutical industry readily adopts new technologies to provide medical advancements, it has been much slower to adopt technology within its marketing efforts, mostly relying on traditional channels and methods. However, the decreasing effectiveness of these traditional channels, given changing physician, patient and consumer trends in today’s increasingly digital society, is forcing an evolution of pharmaceutical marketing strategies. The report examines how the effective implementation of various digital marketing approaches, in conjunction with traditional channels in an integrated multichannel marketing strategy, has the ability to expand marketing reach, increase audience engagement, provide higher return on investment (ROI) and improve methods of tracking ROI for pharmaceutical companies.


    Complete Report is Available@ www.reportsweb.com/inquiry&RW00020804/sample

    The report features an overview of the various marketing channels available to pharma, and examines the factors driving change within this field. It analyzes how a wide range of digital marketing methods can be effectively integrated into a synergistic multichannel marketing strategy that allows both traditional and newer channels to complement each other. Analysis of the main challenges and risks associated with digital marketing methods, in addition to potential solutions and approaches to overcoming them, is provided. Real-world case studies of marketing strategies and campaigns employed by pharma are also included.

    Publisher conducted extensive research in order to provide a comprehensive view of the evolving pharmaceutical marketing landscape. In addition to garnering views from internal experts Publisher conducted an extensive interview with pharmaphorum CEO and founder Paul Tunnah, who is an experienced industry thought leader and advisor with a specialist focus on cross-stakeholder communication, digital/social media engagement and collaborative innovation. Based on the totality of our research, strategic recommendations and guidelines are provided throughout the report for the effective implementation of digital marketing strategies within a coherent overall multichannel marketing strategy.

    This new report adds to our unique portfolio of trusted industry analyses that enable our clients to assess the most promising areas in the market and exploit key business opportunities.

    Inquiry for Report@ www.reportsweb.com/inquiry&RW00020804/buying

    Scope
    - What are the different marketing channels available to pharma?
    - What factors are driving change in the traditional pharma marketing strategy?
    - What is a multichannel marketing strategy? What are the benefits, and how can they be implemented effectively?
    - What are the different digital marketing strategies that pharma can utilize in order to keep pace with changing needs, and maintain ROI? How can these be implemented effectively?
    - What are the main challenges and risks associated with digital marketing methods, and what are some potential solutions and approaches to overcoming these?
    - What digital marketing strategies and campaigns have been employed by pharma in recent years?
    - What are the key strategic recommendations and guidelines for digital marketing as part of an integrated multichannel marketing strategy?

    Key Reasons to Purchase
    - Understand how and why pharmaceutical marketing is evolving
    - Gain insights into various digital marketing strategies, their benefits and key features, and recommendations on how to effectively implement them
    - Assess examples of approaches taken by other companies in the field
    - Understand the challenges and risks involved in pharma digital marketing, and ways in which you can plan for these challenges and minimize risks

    Buy Report@ www.reportsweb.com/buy&RW00020804/buy/2995


    Rajat Sahni
    +1-646-491-9876
    sales@reportsweb.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, May 09, 2018 ) Publisher’s latest report, "Strategic Trends in Private Equity and Venture Capital Funding for Healthcare" provides a comprehensive analysis on emerging investment trends within the healthcare industry. Private equity (PE) and venture capital (VC) funds have been important participants in a wide range of industries for many decades - particularly the healthcare industry. They remain one of the few sources of funding for innovative start-up companies, which often bring disruptive technologies and life-saving medical interventions to the market.

    This report provides in-depth qualitative and quantitative analyses of global and regional trends that have shaped the current healthcare PE and VC landscape, particularly from 2006 to 2015. It provides multilevel analyses that identify geographical markets and therapy areas attracting noteworthy investments. Analyses of key investment indicators in the US, including levels of fundraising activities by PE and VC companies, VC investments by industry sector, and VC-backed exits and venture financing trends - particularly for early-stage healthcare companies - are also included.

    Complete Report is Available@ www.reportsweb.com/inquiry&RW00020737/sample?source=op-SM

    Information from our robust, industry-leading databases shows that global values of completed equity offerings in the healthcare industry are continuing their upward trend, reaching record highs in recent years. Quantitative analyses of equity offerings in the healthcare sector from 2006 to 2015 are provided alongside trends in healthcare VC-backed initial public offerings (IPOs) in the US. Top healthcare IPOs are reviewed in detail, with company profiles that include product pipelines showing therapy areas of focus, indications and product development stages.

    The report also includes forecasts for the outlook for PE and VC firms investing in the healthcare sector. VC investment in early-stage healthcare companies continues to decline, and has almost completely disappeared in certain countries. The report discusses new financing models that are emerging and replacing traditional VC financing models, including case studies showcasing recent success stories.

    Publisher conducted extensive research in order to provide a comprehensive view of the strategic trends in PE and VC funding for healthcare. This new report adds to our unique portfolio of trusted industry analyses that enable our clients to assess the most promising areas in the market and exploit key business opportunities.

    Inquiry for Report@ www.reportsweb.com/inquiry&RW00020737/buying?source=op-SM

    Report Scope
    - How important are PE and VC funds to the future development of the healthcare industry?
    - How does the venture-backed healthcare innovation model work?
    - What have been the global trends in healthcare PE and VC over the last decade in terms of deal activity (volume) and value?
    - Which geographical markets are attracting noteworthy healthcare investments from PE and VC firms, and which will drive investments in the future?
    - Which therapy areas attracted the most PE and VC investments by value in the last two years and what are the reasons for these trends?
    - How much capital did the top healthcare PE and VC deals raise in 2015, and which investment and healthcare companies were involved?
    - What are the new financing models being adopted by early-stage healthcare companies in the face of the declining availability of VC funds?
    - How did the 2008 global financial crisis affect VC and PE investments in healthcare, in both the short and longer term?
    - How is the healthcare industry performing compared with other industry sectors in terms of attracting VC investments in the US?
    - What are the risks if investments in the healthcare industry decrease significantly?
    - How are VC firms likely to react to increasing competition in the healthcare sector in the coming years?
    - What specific factors will continue to drive investment in the healthcare industry in the coming years?

    Key Reasons to Purchase
    This report will allow you to -
    - Gain insightful analyses and understanding of PE and VC dynamics in the healthcare industry. The report comprehensively describes and assesses the most important factors driving and restraining investments in this industry by assessing key investment information and parameters over the last decade.
    - Assess quantitative and qualitative trends shaping deal activity in the healthcare sector. Publisher employed a multi-faceted research approach that involved the analysis of a variety of secondary research sources and the interrogation of proprietary databases, to provide a complete and objective view of industry and investment dynamics.
    - Gain insight on upcoming trends and factors influencing global healthcare investments.

    Buy Report@ www.reportsweb.com/buy&RW00020737/buy/2995?source=op-SM


    Rajat Sahni
    +1-646-491-9876
    sales@reportsweb.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, May 09, 2018 ) GBI Research's latest report, "Monoclonal Antibodies-Global Trends in the Competitive, Technological and R&D Landscape" discusses both the pipeline and market shares of Monoclonal Antibodies (mAbs) across a number of therapy areas. mAbs are defined as a collection of antibodies produced from a single B-cell clone. These antibodies therefore share binding specificity towards a certain antigen, and can be used as a means of targeted therapy within a number of indications across the pharmaceutical market.

    mAbs have been in development in humans since the mid-1970s, and a substantial number of mAb products have entered the market. However, the majority are still in early-stage development, indicating delays and setbacks in the progression of potential products. Despite this, mAbs are the largest and fastest-growing segment of the biopharmaceutical sector, and account for almost half of the global revenue accrued from this area annually.


    Complete Report is Available@ www.reportsweb.com/inquiry&RW00011199424/sample

    The pipeline is highly active, with 2,836 mAbs currently in development. Most are at an early stage of development, with 76% at the Discovery or Preclinical stage. Additionally, there are currently 85 mAb programs in Phase III development, and 22 at the Pre-registration stage, accounting for just under 4% of the total mAb pipeline.

    This CBR report provides a comprehensive view of the clinical, R&D, commercial and competitive landscape of mAbs, and assesses key developments in manufacturing and development, covering strategies to combat challenges associated with the use of mAbs in human patients.

    Scope
    -While many mAbs that enter the market achieve commercial success, a large proportion are stuck at early-stage development:
    -What strategies can be put in place to advance the production of mAbs-
    -What strategies can be used to improve both the affinity and therapeutic efficacy of mAbs-
    -What are the relative advantages and disadvantages of each mAb type, and which hold the most promise-
    -What proportion of the overall mAb R&D pipeline is occupied by each mAb type-
    -In which therapy areas is there the highest level of R&D activity for mAbs-
    -Which stage of development accounts for the majority of the pipeline-
    -How do mAbs fit into the overall portfolios of companies developing them-
    -What is the level of involvement in mAbs research for the top 15 Big Pharma companies-

    Inquiry for Report@ www.reportsweb.com/inquiry&RW00011199424/buying

    Key Reasons to Purchase
    -Understand the current status of the field of therapeutic mAbs, and the relative clinical and commercial success of currently marketed products, comprising Humira, Remicade, Rituxan, Avastin, Herceptin, Opdivo, Lucentis, Stelara and Soliris
    -Assess the pipeline for mAbs split by therapy area, mAb type, and stage of development. Additionally, a granular assessment of the pipeline is provided across the four most active therapy areas for mAbs: oncology, infectious diseases, immunology and central nervous system disorders
    -Gain a picture of the current competitive landscape, with a detailed breakdown of the companies actively involved in the mAb pipeline. Understand the level of involvement of Big Pharma companies, and the extent to which mAbs fit into the portfolios of companies in this field. Additionally, a highly granular breakdown of companies developing mAbs is provided.


    Rajat Sahni
    +1-646-491-9876
    sales@reportsweb.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, May 09, 2018 ) GBI Research's latest report Mobile Health (mHealth) Technologies: Global Market Prospects - Featuring Expert Panel Views from Industry Survey 2017 provides a comprehensive analysis of the mHealth landscape. GBI Research conducted an extensive industry survey of 65 experts from the pharmaceutical, medical devices, healthcare and healthcare IT industries - including organizations that already implement mHealth solutions and services, and those that do not. The survey gathered experience and opinion on the use of mHealth, and insights on key trends for the present and future use of these technologies, particularly within the pharmaceutical industry. The findings from the survey and results from secondary research efforts have been amalgamated with GBI's own analytical views to provide an assessment that is comprehensive in outlook.

    mHealth is a branch of eHealth, and commonly defined as the use of modern information and communication technologies to meet needs of citizens, patients, healthcare professionals, healthcare providers as well as policy markets. It can have a significant impact on consumers and on all aspects of the pharmaceutical and healthcare sector, and companies are making large investments to leverage these technologies more effectively. mHealth technologies are already a reality in both developed and developing countries, and their uptake is expected to significantly increase in the near future, particularly as the overall healthcare industry continues to shift towards value-based medicine, and due to the increasing need for more cost-effective means to deliver healthcare and to demonstrate the value and effectiveness of medical treatments.

    Complete Report is Available@ http://www.reportsweb.com/inquiry&RW0001866902/sample

    The report features an overview of mHealth solutions and services and its place within the pharmaceutical industry. It examines the factors driving and necessitating the use of these technologies within this industry, and provides detailed examples of how different solutions could be used to provide direct benefits to pharmaceutical companies, healthcare institutions and patients. There is also an analysis of the main challenges surrounding these technologies, as well as case studies of how companies are already implementing mHealth, and deal with some of the challenges. Finally, based on the totality of the survey results and research, strategic recommendations are provided for the effective implementation of new mHealth initiatives.

    The results of GBI's latest industry survey provide insightful analyses from different expert panels, including results from key geographical markets. The survey examined key issues, such the areas where pharmaceutical organizations are currently utilizing mHealth; where they believe it can have the most impact; the main barriers to uptake and driving factors; the likelihood of increasing investment within the next five years; and the overall attitude towards the use of these technologies within the pharmaceutical industry.

    Inquiry for Report@ http://www.reportsweb.com/inquiry&RW0001866902/buying

    GBI Research conducted extensive research to provide a comprehensive view of mHealth solutions and services. This new report adds to our unique portfolio of trusted industry analyses that enable our clients to assess the most promising areas in the market and exploit key business opportunities.

    Scope
    - What are mHealth technologies? What is their place within the pharmaceutical industry?
    - How prevalent is the use of mHealth technologies in the pharmaceutical, healthcare and healthcare IT industries?
    - What are the main driving factors necessitating the use of mHealth? What is the relative importance of these factors?
    - What are the commercial benefits that the use of mHealth solutions and services can provide across the pharmaceutical value chain?
    - In which areas are organizations currently using mHealth, and where do they feel it will have the most impact in the next five years?
    - What are the main challenges associated with mHealth technologies? What is the relative importance of these factors across key geographical markets? For the organizations that do not yet utilize mHealth solutions, what specific reasons have led to this decision?
    - What is the likelihood that organizations that already use mHealth will increase their investment within the next five years? Will those that do not currently invest in the technology begin doing so over this period?
    - How can mHealth initiatives be effectively implemented within an organization?
    - What is the overall opinion of industry experts on the use of mHealth technologies?

    Key Reasons to Purchase:
    - Gain insightful analyses and comprehensive understanding of mHealth technologies
    - Understand the key drivers necessitating the use of mHealth and the main barriers to implementation
    - Understand the views of 65 different organizations within the industry on mHealth
    - Assess the most relevant uses of mHealth solutions and services within your company, and effective ways of implementing mHealth initiatives

    Buy Report@ http://www.reportsweb.com/buy&RW0001866902/buy/2995



    Rajat Sahni
    +1-646-491-9876
    sales@reportsweb.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, May 09, 2018 ) GBI Research's latest report, "Gene Therapies: A Diverse Range of Technologies with a Promising Long-Term Outlook" discusses all gene therapies under the broad criteria of genetic material introduced to the cell for a therapeutic purpose. It includes not only the insertion of a gene into the cell for expression, but also gene silencing with RNA interference (RNAi) and antisense RNA, aptamers (DNA or RNA polymers which bind to a protein target), and oncolytic viruses.

    Gene therapies have been in development in humans for 25 years, and a number of products have begun to enter the pharmaceutical market. However, due to various challenges and clinical trial setbacks, progress in developing this technology and achieving suitability for commercial usage has been slow. Gene therapies only account for a marginal market share and many efficacy and safety concerns remain unaddressed. However, the pipeline is robust; 906 pipeline gene therapies are currently in development. Most are at an early stage of development, with 76% at the Discovery or Preclinical stage. However, there are currently 23 gene therapy programs in Phase III development and two at the Pre-registration stage. This indicates that although gene therapies are beginning to reach the market after two decades of research in humans, the majority remain in relatively early development.

    This CBR report provides a comprehensive view of the clinical, R&D, commercial and competitive landscape of Gene Therapy, and assesses key developments in delivery vector technology, and challenges and advances associated with the production of such vectors.

    Complete Report is Available@ http://www.reportsweb.com/inquiry&RW0001170006/sample?source=emailwire-sm

    Scope
    Despite 25 years of clinical research, only a few gene therapies of all types have reached the market globally, and none have achieved strong clinical or commercial success -
    - Why do gene therapies still occupy only a minimal market share in their respective indications?
    - What can be learned from the gene therapies that have already reached the market?
    A number of different viral and non-viral vector types are currently in development for the delivery of gene therapies -
    - What are the relative advantages and disadvantages of each vector type and which hold the most promise?
    - What proportion of the overall gene therapy R&D pipeline is occupied by each vector type?
    The current pipeline for gene therapies is diverse in terms of the approaches and vectors covered; 50% are gene silencing therapies, while 31% involve the insertion of a functional gene -
    - In which therapy areas is there the highest level of R&D activity for gene therapies?
    - At which stage of development does the majority of pipeline gene therapies reside?
    - What is the proportion of the pipeline occupied by each intervention and vector type overall?
    A number of companies are currently actively developing pipeline gene therapies, including private, public and institutional enterprises -
    - How do gene therapies fit into the overall portfolios of these companies?
    - What is the level of involvement in gene therapy research from the top 20 Big Pharma companies?

    Key Reasons to Purchase
    This report will allow you to -
    - Understand the current status of the field of therapeutic gene therapies, and the relative clinical and commercial success of currently marketed products, comprising Glybera, Kynamro, Macugen, Vitravene, Gendicine, Oncorine, and Neovasculgen.
    - Assess the pipeline for gene therapies split by therapy area, vector type and intervention type, and stage of development. Additionally, a granular assessment of the pipeline is provided across the four major therapy areas for gene therapy: oncology, infectious diseases, central nervous system disorders, and genetic disorders.
    - Gain a picture of the current competitive landscape, with a detailed breakdown of companies actively involved in the gene therapy pipeline. Understand the level of involvement on the part of big pharma companies, and the extent to which gene therapies fit into the overall portfolios of companies in this field. Additionally, a highly granular breakdown of companies developing multiple gene therapies is provided.

    Inquiry for Report@ http://www.reportsweb.com/inquiry&RW0001170006/buying?source=emailwire-sm

    Table Of Content:
    Gene Therapy Overview
    Types of Gene Therapy
    Types of Intervention
    Types of Vector
    Currently Approved Gene Therapies
    Glybera (alipogene tiparvovec)
    Kynamro (mipomersen)
    Macugen (pegaptanib)
    Vitravene (fomivirsen)
    Gendicine (rAd-p53)
    Oncorine (rAd5-H101)
    Neovasculgen (Pl-VEGF165)
    Gene Therapy Production Strategies
    Production of Viral Vectors
    Case Study: Challenges in the Manufacture of AAV Vectors
    Challenges to Gene Therapy Development
    Gene Therapy Pipeline
    Gene Therapy Pipeline by Therapy Area and Stage of Development
    Gene Therapy Pipeline by Intervention and Vector Type
    Company Positioning
    Companies by Therapy Area
    Companies by Stage of Development
    Companies by Intervention Type
    Companies by Vector Type
    Conclusion
    Appendix
    References
    About GBI Research


    Rajat Sahni
    +1-646-491-9876
    sales@reportsweb.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, May 09, 2018 )
    The "Global Cardiac Rhythm Management Market Analysis to 2025" is a specialized and in-depth study of the cardiac rhythm management industry with a focus on the global market trend. The report aims to provide an overview of global cardiac rhythm management market with detailed market segmentation by product, end user, and geography. The global cardiac rhythm management market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.


    Cardiac Rhythm Management (CRM) is a procedure to manage proper functioning of the heart. CRM can be accomplished using devices such as, defibrillators, pacemakers, and cardiac resynchronization therapy devices, among others. CRM helps in accurate monitoring and treatment in patients suffering from heart disease, strokes, and high blood pressure. These CRM devices are used in hospitals, and home & ambulatory care for enhanced treatment.

    Get Free Sample Copy of this report at http://www.reportsweb.com/inquiry&RW00011776998/sample

    List of Companies

    General Electric Company
    BIOTRONIK
    Medtronic
    Boston Scientific Corporation
    Koninklijke Philips N.V.
    Jude Medical, Inc. (acquired by Abbott)
    LivaNova PLC
    Mortara Instrument
    Cardiac Science
    Schiller
    The growing cardiovascular diseases; and increasing level of smoking habits, cholesterol levels, & consumption of alcohol, are the major drivers which are likely to boost the growth of cardiac rhythm management market. Growing technological advancements, rising demand of compact devices, and growing geriatric population are likely to add new opportunities for this market in the coming years.

    The report provides a detailed overview on the industry including both qualitative and quantitative information. It provides overview and forecast of the global cardiac rhythm management market based on product and end user. It also provides market size and forecast till 2025 for overall cardiac rhythm management market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 countries globally along with current trend and opportunities prevailing in the region.

    Get Discount of this report: http://www.reportsweb.com/inquiry&RW00011776998/discount

    The report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.

    The report also includes the profiles of key cardiac rhythm management manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years. Some of the key players influencing the market are General Electric Company, BIOTRONIK, Medtronic, Boston Scientific Corporation, Koninklijke Philips N.V., St. Jude Medical, Inc. (acquired by Abbott), LivaNova PLC, Mortara Instrument, Cardiac Science, Schiller, among others.

    Place an Inquire before Purchase “Global Cardiac Rhythm Management Market Size, Status and Forecast 2025” @ http://www.reportsweb.com/inquiry&RW00011776998/buying

    (Note: If you have any special requirements, please let us know and we will offer you the report as you want.)


    Rajat Sahni
    +1-646-491-9876
    sales@reportsweb.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, May 09, 2018 ) GBI Research's latest report, "Biobanking: Developing Smart, Sustainable and Ethically Compliant Biorepositories for the Future" discusses fundamental concepts in biobanking and recent technology advancements in the field. The report also describes ethical and regulatory concerns in biobanking as well as the economic challenges and opportunities surrounding this industry. Furthermore, this report provides strategic recommendations on how to overcome some of the most critical economic, technological and ethical challenges facing this fast-growing sector.

    Biobanks collect human biospecimens and associated data for medical-scientific research, and organize samples and data in a systematic way for use by others. The importance of biobanks lies in determining the most effective way to store that information and make it available when required. Biobanks may collect different samples from diseased or healthy individuals in various settings. The integration of novel tools such as big data techniques, coupled with the increasing industry need for high-quality biospecimens for research, will lead to expanding biospecimen collections, ultimately resulting in the growth of this sector. Biobanks currently exist on every continent with most located in North America, followed by Europe. Australia has the highest number of biobanks in the Asia-Pacific region whilst India has the highest number of biobanks, when considering the developing economies only.

    Complete Report is Available@ http://www.reportsweb.com/inquiry&RW0001170008/sample

    The development of a biobank depends upon people's willingness to donate their samples for research and to agree to sample storage. The participation and support of the public is therefore of crucial importance as their attitude towards biobanking activities will determine the success of many of these organizations.

    Scope
    - What are the fundamentals of biobanking?
    - How can biobanks be classified and what are their different applications in healthcare?
    - What are the economic challenges faced by biobanks and how can these be overcome?
    - What are the most recent technology advancements in biobanking?
    - What role does biobanking play in drug discovery and clinical trials?
    - How are biobanks distributed geographically?
    - What are the prospects of Big Data and associated technologies within biobanking?
    - What are the technological and legal challenges?
    - What are the main healthcare opportunities that can be leveraged?
    - What is the public attitude towards various biobanking activities?
    - What are the challenges in obtaining informed consent from donors and what strategies can biobanks adopt to overcome these challenges?
    - What are the current ethical and regulatory challenges in biobanking?
    - What is the role and importance of the international charter of principles for data sharing between biobanks?
    - What are the main intellectual property right opportunities and challenges within biobanking? How can biobanks overcome these challenges and mitigate potential risks?
    - What is the need for process harmonization between biobanks?

    Inquiry for Report@ http://www.reportsweb.com/inquiry&RW0001170008/buying

    Key Reasons to Purchase
    This report will allow you to -
    - Gain insights in the biobanking industry: This report describes fundamental concepts in biobanking, biobank classification as well as economic, technological and ethical challenges surrounding these organizations. Learn how biobanks can overcome these challenges through best practice guidelines and strategic recommendations.
    - Understand the role of biobanks in research and development: This report demonstrates the relationship between biobanks and R&D groups.
    - Gain analysis on the distribution of biobanks in key regions and countries: This includes detailed analysis on the number of biobanks within each of the key regions and countries.
    - Review and assess recent advances in biobanking technologies: This includes technology innovations in specimen collection, storage, temperature maintenance, consumables, data handling, transportation of biospecimens, and the integration of big data technologies in biobanking activities.
    - Understand public views on biobanking activities: Learn about the various public concerns on biobanking, their attitude towards research, and how consent issues can be addressed through novel frameworks and technology adoption.
    - Assess ethics, regulations, and harmonization needs in biobanking: This in-depth report provides analysis on ethical, regulatory and harmonization requirements in the biobanking sector.


    Rajat Sahni
    +1-646-491-9876
    sales@reportsweb.com

    Source: EmailWire.Com

older | 1 | .... | 1031 | 1032 | (Page 1033) | 1034 | 1035 | .... | 1118 | newer